Alpha Crest Capital Management LLC Corcept Therapeutics Inc Transaction History

Alpha Crest Capital Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $262,017 - $308,904	-10,608 Reduced 17.56%	49,810 $1.28 Million
Q2 2022 Aug 11, 2022	SELL	$17.33 - $25.3 $998,987 - $1.46 Million	-57,645 Reduced 48.83%	60,418 $1.44 Million
Q1 2022 May 12, 2022	SELL	$16.53 - $25.21 $194,954 - $297,326	-11,794 Reduced 9.08%	118,063 $2.66 Million
Q4 2021 Feb 09, 2022	BUY	$17.1 - $23.34 $488,410 - $666,637	28,562 Added 28.2%	129,857 $2.57 Million
Q3 2021 Nov 10, 2021	BUY	$19.68 - $22.53 $1.26 Million - $1.44 Million	64,048 Added 171.95%	101,295 $1.99 Million
Q2 2021 Aug 12, 2021	SELL	$19.97 - $24.43 $703,902 - $861,108	-35,248 Reduced 48.62%	37,247 $819,000
Q1 2021 May 13, 2021	BUY	$23.49 - $30.56 $1.7 Million - $2.22 Million	72,495 New	72,495 $1.73 Million
Q3 2020 Nov 12, 2020	SELL	$12.46 - $19.98 $464,695 - $745,154	-37,295 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$11.0 - $18.26 $410,245 - $681,006	37,295 New	37,295 $627,000
Q1 2020 May 13, 2020	SELL	$10.11 - $14.04 $309,366 - $429,624	-30,600 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$12.06 - $16.96 $681,390 - $958,240	-56,500 Reduced 64.87%	30,600 $370,000
Q3 2019 Nov 12, 2019	BUY	$10.41 - $14.66 $604,821 - $851,746	58,100 Added 200.34%	87,100 $1.23 Million
Q2 2019 Aug 12, 2019	SELL	$9.78 - $12.76 $404,892 - $528,264	-41,400 Reduced 58.81%	29,000 $323,000
Q1 2019 May 10, 2019	BUY	$10.03 - $15.71 $510,526 - $799,639	50,900 Added 261.03%	70,400 $826,000
Q4 2018 Feb 11, 2019	BUY	$11.29 - $17.19 $220,154 - $335,205	19,500 New	19,500 $261,000

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.